mu 3 session series

55
Meaningful Use Measures Series Objectives related to drugs, medications, and eRx for Eligible Professionals 1

Upload: ryo

Post on 13-Feb-2016

61 views

Category:

Documents


5 download

DESCRIPTION

Meaningful Use Measures Series Objectives related to drugs, medications, and eRx for Eligible Professionals. MU 3 Session Series. Physician Meaningful Use 3 Session Series Sept. 20 - Session #1  Drug, Medication, eRx related Oct. 18 - Session #2  Recording Patient Data - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: MU 3 Session Series

Meaningful Use Measures Series

Objectives related to drugs, medications, and eRx for Eligible Professionals 1

Page 2: MU 3 Session Series

MU 3 Session Series

Physician Meaningful Use 3 Session Series

1) Sept. 20 - Session #1  Drug, Medication, eRx related

2) Oct. 18 - Session #2  Recording Patient Data3) Nov. 15 - Session #3  Interoperability,

Exchanging Data Outside the Clinic Other Than to Patients

TAKEAWAY: Use Your resources – GA-HITREC & HomeTown Health

2

Page 3: MU 3 Session Series

PHYSICIAN Incentive Programs

1) Medicaid and Medicare Incentive Programs2) Medicare Physician Quality Reporting Initiative

(PQRI) 3) Electronic Prescribing (eRx) Incentive Program

• If the EP chooses to participate in the Medicare EHR Incentive Program, they cannot participate in the Medicare eRx Incentive Program simultaneously in the same program year.

• If the EP chooses to participate in the Medicaid EHR Incentive Program, they can participate in the Medicare eRx Incentive Program simultaneously.

3

Page 4: MU 3 Session Series

PHYSICIAN Incentive Programs

The Physician Quality Reporting Program (PQRI) will provide a 1 percent payment incentive for 2011, 0.5 percent incentive payment from 2012 through 2104,

Penalties for non-participation in PQRI of 1.5 percent in 2015 and 2 percent in 2015.

4

Page 5: MU 3 Session Series

PHYSICIAN Incentive Programs

5

Page 6: MU 3 Session Series

PHYSICIAN Incentive Programs

Medicare Incentive Can receive up to $44,000.00 in incentives, and up to

$48,400.00 if practicing in a Health Provider Shortage Area (HPSA)

Required to demonstrate meaningful use of certified EHR technology every year to qualify for payment and participate by 2nd year - 2012 to receive the maximum incentive payment

Medicaid Incentive Can receive up to $63,750.00 in incentives Can qualify for payment for adopting, implementing,

upgrading or demonstrating meaningful use of certified EHR technology in first participation year. Required to demonstrate meaningful use in each subsequent year to qualify for payment

Must participate by 2016 to receive the maximum incentive payment

6

Page 7: MU 3 Session Series

E-Prescribing (eRx) Incentive Program

eRx BACKGROUND Section 132 of the Medicare Improvements for Patients and

Providers Act of 2008 (MIPPA) authorizes a separate incentive program for eligible professionals who are successful electronic prescribers as defined by MIPPA. This is a separate incentive and is in addition to the Physician Quality Reporting System (Physician Quality Reporting) program. Eligible professionals do not have to be reporting in the Physician Quality Reporting program to participate in the eRx Incentive program.

For 2011, a 1 percent incentive payment can be paid to eligible professionals who successfully prescribe (as defined by the statute) their patient’s medications via a qualified eRx system.

7

Page 8: MU 3 Session Series

E-Prescribing (eRx) Incentive Program

eRx Definition eRx is a prescriber’s ability

to electronically send an accurate, error-free and understandable prescription directly to a pharmacy from the point-of-care and is an important element in improving the quality of patient care.

8

Page 9: MU 3 Session Series

E-Prescribing (eRx) Incentive Program

eRx Changes Effective July 2011 eRx is no longer included in the Physician Quality

Reporting Measures List. The eRx incentive is 1 percent of the Physician

Fee Schedule (PFS) allowed amount. The incentive is only available to authorized

prescribers under their state laws. • Georgia is an approved state

9

Page 10: MU 3 Session Series

E-Prescribing (eRx) Incentive Program

eRx Overview eRx does not require the provider to participate in

the Physician Quality Reporting program. Eligible professionals may participate in either or

both incentive programs and could potentially receive two incentive payments.

eRx has no sign-up or registration to participate in the program.

Eligible professionals must have a qualified system to participate.

10

Page 11: MU 3 Session Series

E-Prescribing (eRx) Incentive Program

eRx Overview eRx can be reported:

• On Medicare Part B claims. • To a qualified registry. • Through a qualified Electronic Health Record (EHR) product.

Ten percent of a successful electronic prescriber’s Medicare Part B covered services must be made up of codes that appear in the eRx measure.

eRx does not require the provider to participate in the Physician Quality Reporting program.

11

Page 12: MU 3 Session Series

E-Prescribing (eRx) Incentive Program

eRx Overview

Medicare Advantage plans are not eligible for this incentive; only Medicare Part B qualifies.

Beginning in 2012, eligible providers who are not successful electronic providers may be subject to payment adjustments (payment reductions). Those not successful will see a reduction in the PFS amount of 1 percent.

FEEDBACK REPORT http://www.cms.gov/ERXIncentive/downloads/200

9eRxFeedbackReportUserGuide_10-12-2010.pdf

12

Page 13: MU 3 Session Series

E-Prescribing (eRx) Incentive Program

Hardship Codes CMS has introduced new codes, referred to as hardship

codes, which should be reported at least one time on a denominator-eligible claim during the 2012 payment adjustment reporting period (if applicable). The payment adjustment period for 2011 is considered January 1, 2011, through June 30, 2011. During this time period, if eligible providers do not report eRx services, those providers will receive a 1 percent physician fee schedule adjustment (fee schedule reductions) in the year 2012.

These codes should be used when an eligible professional wishes to request a significant hardship exemption from the application of the 2012 payment adjustment because the provider is unable to submit electronic prescriptions due to some type of system hardship.

13

Page 14: MU 3 Session Series

E-Prescribing (eRx) Incentive Program

Examples of system hardship:

• Rural area without Internet access.

• Limited pharmacies accepting eRx.

• Does not have prescribing privileges.

14

Page 15: MU 3 Session Series

E-Prescribing (eRx) Incentive Program

Hardship Codes G8642 The eligible professional practices in a rural area

without sufficient high-speed Internet access and requests a hardship exemption from the application of the payment adjustment under Section 1848(a)(5)(A) of the Social Security Act.

G8643 The eligible professional practices in an area without sufficient available pharmacies for eRx and requests a hardship exemption from the application of payment adjustment under Section 1848(a)(5)(A) of the Social Security Act.

G8644 may be used when an eligible professional does not have prescribing privileges.

If these codes are used, the eligible professional may not be considered for a payment adjustment.

15

Page 16: MU 3 Session Series

E-Prescribing (eRx) Incentive Program

Hardship Codes

16

Page 17: MU 3 Session Series

E-Prescribing (eRx) Incentive Program

POLL QUESTION

17

Page 18: MU 3 Session Series

25 Objectives in 5 Priority Outcomes

Improving quality, safety, efficiency and reducing health disparities

Engage patients and families in their health care

Ensure adequate privacy and security protections for personal health information

Improve care coordination Improving population and public health

18

Page 19: MU 3 Session Series

25 Objectives in 5 Priority Outcomes

19

Stage I Meaningful Use for 2011 – Eligible Professionals must complete: 15 core objectives (e.g., maintain active

medication list, etc.) 5 objectives out of 10 from menu set (e.g.,

implement drug formulary checks, etc.) 6 total Clinical Quality Measures(CQM) (3 core or

alternate core, and 3 out of 38 from additional set)

Page 20: MU 3 Session Series

Objective Requirements

20

15 Core Set Objectives

Eligible Professionals must meet all Core Objectives to qualify for incentive payments

Page 21: MU 3 Session Series

Objective Requirements

21

10 Menu Set Objectives

Eligible Professionals will defer 5 Menu

Objectives

One of the remaining objectives must be

from Improving population and public

health priority

Page 22: MU 3 Session Series

Measures Attestation

22

Yes/No

• Have done the objective or not

Percentage Based

• Numerator/Denominator

Page 23: MU 3 Session Series

Exclusions

23

Some MU objectives are not applicable to every provider’s clinical practice

They would not have any eligible patients or actions for the measure denominator

Exclusions do not count against the 5 deferred Menu set objectives

Page 24: MU 3 Session Series

Defining Terms

24

Certified EHR Technology

• To achieve meaningful use, a provider will have to use EHR technology certified by entities named by the Federal Government.

• The Certified HIT Product List (CHPL) provides the authoritative, comprehensive listing of Complete EHRs and EHR Modules that have been tested and certified under the Temporary Certification Program maintained by the Office of the National Coordinator for Health IT (ONC) For a list of Meaningful Use certified vendors visit http://onc-chpl.force.com/ehrcert.

• Certification status may effect a provider’s EHR selection. It gives the provider confidence the EHR contains the functionality needed to achieve meaningful use.

Page 25: MU 3 Session Series

Defining Terms

25

EHR Reporting Period

• Medicare Incentive• The first year demonstrate meaningful use report on objectives and measures for a

continuous 90 days. After that first year, the reporting period is the entire calendar year.• Medicaid Incentive

• Eligible professionals who adopt, implement, upgrade or meaningfully use certified electronic health record technology in their first year of participation in the program and demonstrate meaningful use for 90 days in the second year. After the second year, the reporting period is the entire calendar year.

Page 26: MU 3 Session Series

Defining Terms

26

Unique Patient

• If a patient is seen by an EP more than once during the EHR reporting period, then for purposes of measurement that patient is only counted once in the denominator for the measure.

• All the measures relying on the term ‘‘unique patient’’ relate to what is contained in the patient’s medical record.

• Not all of this information will need to be updated or even be needed by the provider at every patient encounter. This is especially true for patients whose encounter frequency is such that they would see the same provider multiple times in the same EHR reporting period.

Page 27: MU 3 Session Series

Defining Terms

27

Patient Encounters

• If a patient is seen by an EP more than once during the EHR reporting period, then for purposes of measurement that denominator for the measure is based on all office visits.

• All the measures relying on the term ‘‘patient encounter’’ relate to what is contained in the patient’s medical record.

Page 28: MU 3 Session Series

E-Prescribing (eRx) Incentive Program

POLL QUESTION

28

Page 29: MU 3 Session Series

Selected Objectives Related to:

29

Drugs Medications

eRx

Page 30: MU 3 Session Series

Core Objective–Use CPOE Objective

30

Objective • Use computerized

provider order entry (CPOE) for medication orders directly entered by any licensed health care provider who can enter orders into the medical record per state, local and provider guidelines

Measures• More than 30% of

all unique patients with at least 1 medication in their medication list seen by the EP have at least 1 medication order entered using CPOE

Exclusions• Any EP who

writes fewer than 100 prescriptions during the EHR reporting period

Page 31: MU 3 Session Series

Attestation Requirements – CPOE

The resulting percentage (Numerator ÷Denominator) must be more than 30 percent in order for an EP to meet this measure. 31

Denominator

• Number of unique patients with at least one medication in their medication list seen by the EP during the EHR reporting period.

Numerator

• The number of patients in the denominator that have at least one medication order entered using CPOE.

Exclusion• EPs who write fewer

than 100 prescriptions during the EHR reporting period would be excluded from this requirement.

• EPs must enter the number of prescriptions written during the EHR reporting period in the Exclusion box to attest to exclusion from this requirement.

Page 32: MU 3 Session Series

Additional Information – CPOE Provider is permitted, but not required, to limit the measure of this

objective to those patients whose records are maintained using certified EHR technology.

Any licensed health care professionals can enter orders into the medical record for purposes of including the order in the numerator for the objective of CPOE if they can enter the order per state, local and professional guidelines.

Order must be entered by someone who can exercise clinical judgment in the case that the entry generates any alerts about possible interactions or other clinical decision support aides. This necessitates that the CPOE occurs when the order first becomes part of the patient’s medical record and before any action can be taken on the order.

Electronic transmittal of the medication order to the pharmacy, laboratory, or diagnostic imaging center is not a requirement for meeting the measure of this objective. However, a separate objective addresses the electronic transmittal of prescriptions and is a requirement for EPs to meet MU.

32

Page 33: MU 3 Session Series

Core Objective – Interaction checks

33

Objective • Implement

drug-drug and drug-allergy interaction checks.

Measures• The EP has

enabled this functionality for the entire EHR reporting period.

Exclusions• None

Page 34: MU 3 Session Series

Attestation Requirements – Interaction Check

34

Yes / No

•Eligible professionals (EPs) must attest YES to having enabled drug-drug and drug-allergy interaction checks for the length of the reporting period to meet this measure.

Page 35: MU 3 Session Series

Core Objective – eRx

35

Objective • Generate and

transmit permissible prescriptions electronically (eRx).

Measures• More than 40

percent of all permissible prescriptions written by the EP are transmitted electronically using certified EHR technology.

Exclusions• Any EP who

writes fewer than 100 prescriptions during the EHR reporting period.

Page 36: MU 3 Session Series

Attestation Requirements – eRx

36

Denominator• Number of

prescriptions written for drugs requiring a prescription in order to be dispensed other than controlled substances during the EHR reporting period.

Numerator

• Number of prescriptions in the denominator generated and transmitted electronically.

Exclusion• EPs who write fewer

than 100 prescriptions during the EHR reporting period would be excluded from this requirement.

• EPs must enter the number of prescriptions written during the EHR reporting period in the Exclusion box to attest to exclusion from this requirement.

The resulting percentage (Numerator ÷Denominator) must be more than 40 percent in order for an EP to meet this measure.

Page 37: MU 3 Session Series

Additional Information – eRx The provider is permitted, but not required, to limit the measure

of this objective to those patients whose records are maintained using certified EHR technology.

Authorizations for items such as durable medical equipment, or other items and services that may require EP authorization before the patient could receive them, are not included in the definition of prescriptions. These are excluded from the numerator and the denominator of the measure.

Instances where patients specifically request a paper prescription may not be excluded from the denominator of this measure. The denominator includes all prescriptions written by the EP during the EHR reporting period.

The guidelines of the recent Dept of Justice IFR allows e-prescribing of controlled substances could not be incorporated into the EHR Incentive Programs. "Permissible prescriptions" will be based on guidelines for prescribing Schedule II-V controlled substances in effect on or before 1/13/10. 37

Page 38: MU 3 Session Series

Additional Information – eRx EPs cannot receive incentive payments for e-prescribing

under both the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) and the Medicare EHR Incentive Program for the same year. However, EPs can receive payments from both the MIPPA E-Prescribing Incentive Program and the Medicaid EHR Incentive program for the same year.

Providers can use intermediary networks that convert information from the certified EHR into a computer-based fax in order to meet this measure as long as the EP generates an electronic Rx and transmits it electronically using the standards of certified EHR technology to the intermediary network, and this results in the Rx being filled without the need for the provider to communicate the Rx in an alternative manner.

38

Page 39: MU 3 Session Series

Additional Information – eRx Rxs transmitted electronically within the same legal entity

don't need to use the NCPDP standards. EHRs must be Certified EHR Technology and meet all applicable certification criteria and be certified as having the capability of meeting the external transmission requirements of §170.304(b).

EPs should include in the numerator and denominator both types of electronic transmissions (those within and outside the organization) for the measure of this objective.

39

Page 40: MU 3 Session Series

Core Objective – Medication List

40

Objective • Maintain active

medication list.

Measures• More than 80

percent of all unique patients seen by the EP have at least one entry (or an indication that the patient is not currently prescribed any medication) recorded as structured data.

Exclusions• None

Page 41: MU 3 Session Series

Attestation Requirements – Med. List

41

Denominator

• Number of unique patients seen by the EP during the EHR reporting period.

Numerator

• Number of patients in the denominator who have a medication (or an indication that the patient is not currently prescribed any medication) recorded as structured data.

The resulting percentage (Numerator ÷Denominator) must be more than 80 percent in order for an EP to meet this measure.

Page 42: MU 3 Session Series

Additional Information – Med. List For patients with no active medications,

an entry must still be made to the active medication list indicating that there are no active medications.

An EP is not required to update this list at every contact with the patient. The EP can then use his or her clinical judgment to decide when additional updating is required.

42

Page 43: MU 3 Session Series

Core Objective – Allergy List

43

Objective • Maintain active

medication allergy list.

Measures• More than 80

percent of all unique patients seen by the EP have at least one entry (or an indication that the patient has no known medication allergies) recorded as structured data.

Exclusions• None

Page 44: MU 3 Session Series

Attestation Requirements – Allergy

44

Denominator

• Number of unique patients seen by the EP during the EHR reporting period.

Numerator• Number of unique patients in

the denominator who have at least one entry (or an indication that the patient has no known medication allergies) recorded as structured data in their medication allergy list.

The resulting percentage (Numerator ÷Denominator) must be more than 80 percent in order for an EP to meet this measure.

Page 45: MU 3 Session Series

Additional Information – Allergy List For patients with no active medication allergies, an

entry must still be made to the active medication allergy list indicating that there are no active medication allergies.

An EP is not required to update this list at every contact with the patient. The measure ensures that the EP has not ignored having a medication allergy list for patients seen during the EHR reporting period and that at least one piece of information on medication allergies is presented to the EP. The EP can then use their judgment in deciding what further probing or updating may be required given the clinical circumstances at hand.

45

Page 46: MU 3 Session Series

Menu Objective – Drug Formulary Checks

46

Objective • Implement drug

formulary checks.

Measures• The EP has

enabled this functionality and has access to at least one internal or external formulary for the entire EHR reporting period.

Exclusions• Any EP who

writes fewer than 100 prescriptions during the EHR reporting period.

Page 47: MU 3 Session Series

Attestation Requirements – Drug Checks

47

Yes/No

•Eligible professionals (EPs) must attest YES to having enabled this functionality and having had access to at least one internal or external formulary for the entire EHR reporting period to meet this measure.

Exclusion

•An EP who writes fewer than 100 prescriptions during the EHR reporting period can be excluded from this objective and associated measure. EPs must enter ‘0’ in the Exclusion box to attest to exclusion from this requirement.

Page 48: MU 3 Session Series

Additional Information – Drug Checks

At a minimum an EP must have at least one formulary that can be queried. This may be an internally developed formulary or an external formulary. The formularies should be relevant for patient care during the prescribing process.

48

Page 49: MU 3 Session Series

Menu Objective–Medication Reconciliation

49

Objective • The EP who

receives a patient from another setting of care or provider of care or believes an encounter is relevant should perform medication reconciliation.

Measures• The EP performs

medication reconciliation for more than 50 percent of transitions of care in which the patient is transitioned into the care of the EP

Exclusions• An EP who

was not the recipient of any transitions of care during the EHR reporting period.

Page 50: MU 3 Session Series

Attestation Requirements – Med. Reconciliation

50

Denominator

• Number of transitions of care during the EHR reporting period for which the EP was the receiving party of the transition.

Numerator

• Number of transitions of care in the denominator where medication reconciliation was performed.

Exclusion• If an EP was not on

the receiving end of any transition of care during the EHR reporting period they would be excluded from this requirement.

• EPs must select NO next to the appropriate exclusion, then click the APPLY button in order to attest to the exclusion.

The resulting percentage (Numerator ÷Denominator) must be more than 50 percent in order for an EP to meet this measure.

Page 51: MU 3 Session Series

Additional Information – Med. Reconciliation

Only patients whose records are maintained using certified EHR technology should be included in the denominator for transitions of care.

In the case of reconciliation following transition of care, the receiving EP should conduct the medication reconciliation.

The measure of this objective does not dictate what information must be included in medication reconciliation. Information included in the process of medication reconciliation is appropriately determined by the provider and patient. 51

Page 52: MU 3 Session Series

E-Prescribing (eRx) Incentive Program

POLL QUESTION

52

Page 53: MU 3 Session Series

Resources CMS Web Site for the Medicare and Medicaid

EHR Incentive Program www.cms.gov/EHRIncentivePrograms

Meaningful Use Measures Links http://www.cms.gov/EHRIncentivePrograms/Downloads/EP-MU-TOC.pdf

ERx Manual http://www.trailblazerhealth.com/Publications/Training%20

Manual/E-Prescribing.pdf Georgia HITREC http://www.ga-hitrec.org/gahitrec/

53

Page 54: MU 3 Session Series

Q&A

54

The patient should be on the forefront of every decision you make

Page 55: MU 3 Session Series

Regional Extension Center

Your Meaningful Use Expert Resource.Contact us today!

55In Partnership with: The Office of the National Coordinator for Health Information Technology (ONC) U.S. Department of Health and Human Services grant 90RC0004/01. IA-HITREC-03/11-219

This presentation is compliments of

www.IowaHITREC.org

For More information go to:www.ga-hitrec.org